Bumper Offer - Urjas oil Just @ Rs. 1
Oflox Eye/Ear Drop is a prescription medicine that is available as a Drops. Urinary Tract Infection, Ear Infection, Bacterial Infections are some of its major therapeutic uses. Other than this, Oflox Eye/Ear Drop has some other therapeutic uses, which have been discussed ahead.
The right dosage of Oflox Eye/Ear Drop depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Oflox Eye/Ear Drop side effects, there are can be others also. These have been listed below. These side effects of Oflox Eye/Ear Drop are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Oflox Eye/Ear Drop is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Oflox Eye/Ear Drop's effects on the liver, heart and kidney, if any, have been listed below.
Oflox Eye/Ear Drop can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Oflox Eye/Ear Drop in conditions like Atrial Fibrillation, Heart Failure, Myasthenia Gravis (MG). Other contraindications of Oflox Eye/Ear Drop have been discussed in the sections ahead.
Besides this, Oflox Eye/Ear Drop may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Oflox Eye/Ear Drop is considered not safe while driving, and is not addictive.
Oflox Eye/Ear Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Oflox Eye/Ear Drop safe for pregnant women?
Oflox may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Oflox again without your doctor's advice.
Is the use of Oflox Eye/Ear Drop safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Oflox. Immediately discontinue Oflox if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Oflox Eye/Ear Drop on the Kidneys?
Oflox rarely affects the kidneys.
What is the effect of Oflox Eye/Ear Drop on the Liver?
Oflox is rarely harmful for the liver.
What is the effect of Oflox Eye/Ear Drop on the Heart?
Oflox is rarely harmful for the heart.
Oflox Eye/Ear Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Mild
If you are suffering from any of the following diseases, you should not take Oflox Eye/Ear Drop unless your doctor advises you to do so -
Is this Oflox Eye/Ear Drop habit forming or addictive?
No, you will not get addicted to Oflox Eye/Ear Drop.
Is it safe to drive or operate heavy machinery when consuming?
After taking Oflox Eye/Ear Drop you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Oflox Eye/Ear Drop is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Oflox Eye/Ear Drop cannot treat any kind of mental disorder.
Interaction between Food and Oflox Eye/Ear Drop
Taking Oflox Eye/Ear Drop with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Oflox Eye/Ear Drop
Consult your doctor before consuming alcohol while taking Oflox Eye/Ear Drop as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)